CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,305 | -23.3% | 72,830 | -5.1% | 0.01% | -22.2% |
Q2 2023 | $4,310 | +15.3% | 76,763 | -7.1% | 0.01% | 0.0% |
Q1 2023 | $3,737 | -1.5% | 82,626 | -11.5% | 0.01% | -10.0% |
Q4 2022 | $3,794 | -99.9% | 93,341 | +17.8% | 0.01% | -33.3% |
Q3 2022 | $5,180,000 | -32.5% | 79,257 | -37.2% | 0.02% | -25.0% |
Q2 2022 | $7,673,000 | +7.2% | 126,259 | +10.7% | 0.02% | +33.3% |
Q1 2022 | $7,160,000 | -9.2% | 114,061 | +9.6% | 0.02% | -16.7% |
Q4 2021 | $7,884,000 | -26.9% | 104,046 | +8.0% | 0.02% | -33.3% |
Q3 2021 | $10,785,000 | -36.0% | 96,352 | -7.5% | 0.03% | -32.5% |
Q2 2021 | $16,862,000 | +16.2% | 104,159 | -12.5% | 0.04% | +2.6% |
Q1 2021 | $14,510,000 | – | 119,081 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |